Apoptosis and (in) Pain-Potential Clinical Implications
Hugo Ribeiro1,2,3,4, Ana Bela Sarmento-Ribeiro2,5,6,7, José Paulo Andrade8,9
1Community Support Team in Palliative Care-Group of Health Centers Gaia, 4430-043 Vila Nova de Gaia, Portugal.
Biomedicines
|June 24, 2022
Summary
Apoptosis, driven by oxidative stress and neuroinflammation, may cause nerve terminal destruction in neuropathic pain. This offers potential new biomarkers and therapies for chronic pain management.
Area of Science:
- Neuroscience
- Cell Biology
- Pain Research
Background:
- Deregulation of apoptosis is implicated in various pathologies.
- Neuropathic pain, a chronic pain state from nervous system damage, has unclear molecular mechanisms.
- Transient receptor potential (TRP) channels in nerve endings respond to tissue injury signals.
Purpose of the Study:
- Review the involvement of apoptosis in pain, focusing on neuropathic pain.
- Examine the roles of oxidative stress and neuroinflammation in apoptosis-related pain.
- Discuss the clinical relevance and potential therapeutic targets.
Main Methods:
- Literature review of studies on apoptosis, TRP channels, oxidative stress, and neuroinflammation in pain.
- Analysis of molecular mechanisms linking these factors to neuropathic pain.
- Exploration of potential biomarkers and therapeutic strategies.
Main Results:
- TRP channels can facilitate calcium influx, activating apoptosis and leading to nerve terminal destruction.
- Oxidative stress and reactive oxygen species (ROS) can trigger apoptosis.
- Proinflammatory cytokines like tumor necrosis factor-α (TNF-α) contribute to neuropathic pain mediation.
Conclusions:
- Oxidative stress and neuroinflammation activate pathways leading to apoptosis and nerve terminal destruction.
- These processes represent potential biomarkers for neuropathic pain.
- Identifying these pathways may lead to novel therapeutic targets for chronic pain.
Related Concept Videos
Apoptosis
11.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Nociception
29.4K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.4K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K


